|
Navigating the Perinatal Journey brings together practical tools, screening guidance, and clinical insights to strengthen perinatal behavioral health care across Washington. Each section can be used independently, so providers can focus on a specific topic area, or as part of a collective toolkit that supports comprehensive perinatal behavioral health care.
Developed with state and university partners, this toolkit provides clear, actionable information for use in clinical and community settings. Download it today to strengthen care, connect with support services, and promote healthy outcomes.
The DC:0-5 is the best-practice diagnostic manual for infants and young children, and it’s required for Apple Health mental health providers. The Apple Health DC:0-5 Crosswalk is a reference tool that helps Apple Health providers ‘crosswalk’ DC:0-5 diagnoses to associated ICD-10 diagnostic codes.
HCA updates the Crosswalk every year, and we solicit community feedback as part of this process. This year, HCA has published a list of proposed updates to the Crosswalk, and you can share your feedback until November 1.
Mental Health Assessment for Young Children (MHAYC) helps providers use best practices for assessing mental health conditions among young children. In a new report, we used medical claims data to look at the impact of MHAYC policies on assessment practices.
The report found that multi-session assessments, a key best practice for infant-early childhood mental health, became more common for young children after MHAYC policies went into effect.
HCA is partnering with the Washington State Institute for Public Policy (WSIPP) on a new project related to prenatal – five mental health. WSIPP is an internationally-recognized, nonpartisan, public research group that conducts applied policy research for the state legislature and other key partners.
Starting in April 2026, WSIPP will be conducting a review of 12 - 14 infant and early childhood mental health (IECMH) and perinatal mental health (PMH) treatment models and analyzing benefit-cost outcomes of treatment.
The final report, expected in June 2027, will be publicly available and will summarize the evidence, present benefit-cost findings where evidence is available, and describe key program characteristics. This information can be used to inform policy and practice decisions regarding high quality, evidence-based treatment services in the early years of life.
|
